Research output per year
Research output per year
Fingerprint
Dive into the research topics where Tufia C Haddad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
Research output
-
Accuracy of an artificial intelligence system for cancer clinical trial eligibility screening: Retrospective pilot study
Haddad, T., Helgeson, J. M., Pomerleau, K. E., Preininger, A. M., Roebuck, M. C., Dankwa-Mullan, I., Jackson, G. P. & Goetz, M. P., Mar 2021, In: JMIR Medical Informatics. 9, 3, e27767.Research output: Contribution to journal › Article › peer-review
Open Access -
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Jalalirad, M., Haddad, T. C., Salisbury, J. L., Radisky, D., Zhang, M., Schroeder, M., Tuma, A., Leof, E., Carter, J. M., Degnim, A. C., Boughey, J. C., Sarkaria, J., Yu, J., Wang, L., Liu, M. C., Zammataro, L., Malatino, L., Galanis, E., Ingle, J. N., Goetz, M. P. & 1 others, , Apr 8 2021, In: Oncogene. 40, 14, p. 2509-2523 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy
Du, L., Yau, C., Brown-Swigart, L., Gould, R., Krings, G., Hirst, G. L., Bedrosian, I., Layman, R. M., Carter, J. M., Klein, M., Venters, S., Shad, S., van der Noordaa, M., Chien, A. J., Haddad, T., Isaacs, C., Pusztai, L., Albain, K., Nanda, R., Tripathy, D. & 12 others, , May 2021, In: Annals of Oncology. 32, 5, p. 642-651 10 p.Research output: Contribution to journal › Article › peer-review
-
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
Haddad, T. C., He, J., O’Sullivan, C. C., Chen, B., Northfelt, D., Dueck, A. C., Ballman, K. V., Tenner, K. S., Linden, H., Sparano, J. A., Hopkins, J. O., De Silva, C., Perez, E. A., Haluska, P. & Goetz, M. P., Jul 2021, In: Breast Cancer Research and Treatment. 188, 2, p. 477-487 11 p.Research output: Contribution to journal › Article › peer-review
-
Sapanisertib plus exemestane or fulvestrant in women with hormone receptor-positive/HER2-negative advanced or metastatic breast cancer
Lim, B., Potter, D. A., Salkeni, M. A., Silverman, P., Haddad, T. C., Forget, F., Awada, A., Canon, J. L., Danso, M., Lortholary, A., Bourgeois, H., Tan-Chiu, E., Vincent, S., Bahamon, B., Galinsky, K. J., Patel, C., Neuwirth, R., Leonard, E. J. & Diamond, J. R., Jun 2021, In: Clinical Cancer Research. 27, 12, p. 3329-3338 10 p.Research output: Contribution to journal › Article › peer-review
Open Access